Comparing the current results to its competitors, Viewray Inc reported Revenue increase in the 1 quarter 2022 by 70.16 % year on year. The sales growth was above Viewray Inc 's competitors' average revenue growth of 4.02 %, achieved in the same quarter.
Edap Tms Sa's business model revolves around providing minimally invasive medical devices and solutions for the treatment of urological diseases, specifically focusing on advanced ultrasound technologies for the diagnosis and treatment of prostate cancer and kidney stones.
Renovorx Inc is a medical technology company specializing in the development of innovative treatments for cardiovascular diseases. Their business model focuses on creating and commercializing minimally invasive therapies for patients suffering from conditions like myocardial infarction and heart failure. By leveraging cutting-edge medical devices and procedures, Renovorx aims to provide effective and efficient treatments that can significantly improve patient outcomes and quality of life.
Koninklijke Philips Nv operates as a diversified technology company, focusing on areas such as healthcare, consumer lifestyle, and lighting. The company provides a wide range of products and solutions, including medical imaging equipment, home appliances, personal care products, and lighting solutions. Philips Nv's business model involves innovation-driven research and development, strategic partnerships, and a global distribution network to deliver its products and services to customers worldwide.
Assure Holdings Corp is a healthcare company focused on providing neurophysiologic testing services to surgeons and healthcare facilities. They specialize in intraoperative neuromonitoring (IONM) and ensure real-time monitoring and assessment of the nervous system during surgeries. Their business model revolves around offering these specialized services to enhance patient safety and surgical outcomes while working closely with surgeons and hospitals.
Icad Inc operates on a business model that focuses on the development and commercialization of innovative cancer detection and therapy solutions. They primarily generate revenue through the sale of their advanced medical devices and software solutions to hospitals, clinics, and research institutions worldwide. Their business strategy revolves around continuous innovation, strategic partnerships, and a commitment to providing effective tools for early detection and treatment of cancer.
Sources:
Viewray Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Viewray Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
